Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1R1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,635
Award facts
- Contract value 100% obligated
- $19,635.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency awarded a $19,635 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The vaccine product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with a completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems.
AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This delivery order for TYPHIM VI vaccine reflects the company's ongoing role as a prime vendor in the Defense Logistics Agency's pharmaceutical supply chain, supporting the medical needs of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's capability to efficiently fulfill government requirements for essential medical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1R1?
SPE2DR26FA1R1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FA1R1 worth?
The government has obligated $19,635 on SPE2DR26FA1R1.
Is contract SPE2DR26FA1R1 an order under another contract?
Yes. SPE2DR26FA1R1 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1R1 competed?
The extent of competition for SPE2DR26FA1R1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award